Pelvic floor dysfunction and obesity

Best Pract Res Clin Obstet Gynaecol. 2023 Aug:90:102389. doi: 10.1016/j.bpobgyn.2023.102389. Epub 2023 Jul 11.

Abstract

Obesity is a growing condition within the society and more patients, who have underlying obesity, are presenting with lower urinary tract symptoms (LUTS) and pelvic floor dysfunction (PFD). The effect of obesity on general health has been well documented, and its impact on the cardiovascular, endocrine, and musculoskeletal systems has been extensively studied. There is now a growing body of evidence on the effects of obesity on the female urogenital system. It seems to influence the prevalence, presentation, assessment, management, and outcome of various types of LUTS and PFD. A holistic approach is needed to assess and manage these patients. A clear understanding of the functions of the pelvic floor and the way it can be affected by obesity is essential in providing holistic care to this group. A frank discussion about patient weight is required in the clinics handling PFD. A multimodal approach to weight loss would help improve PFD symptoms and progression. Patients with obesity should still be offered standard treatment options for all PFDs and should not be forced to lose weight as a prerequisite before starting treatment. However, they should also be made aware of the impediments that being overweight adds to their care and their expectations should be managed accordingly.

Keywords: Detrusor overactivity (DO); Lower urinary tract symptoms (LUTS); Obesity; Overactive bladder symptoms (OAB); Overweight; Pelvic floor dysfunction (PFD); Urinary incontinence.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Obesity / complications
  • Obesity / epidemiology
  • Obesity / therapy
  • Overweight
  • Pelvic Floor
  • Pelvic Floor Disorders* / epidemiology
  • Pelvic Floor Disorders* / etiology
  • Pelvic Floor Disorders* / therapy
  • Pelvic Organ Prolapse* / therapy
  • Surveys and Questionnaires